Related Experiment Video
Updated: Jun 25, 2026

10:05
Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells
Published on: September 30, 2018
Mapping metabolic reprogramming dynamics across pancreatic neuroendocrine tumor cell differentiation at single-cell
1Endocrine Department, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou Normal University, Huzhou, Zhejiang, China.
Frontiers in Genetics
|June 24, 2026
Summary
Pancreatic neuroendocrine tumor (pNET) cells shift metabolic states from oxidative phosphorylation (OXPHOS) to glycolysis during differentiation. Key genes like MALAT1 regulate this transition, offering potential therapeutic targets for pNETs.
Area of Science:
- Oncology
- Metabolic Biology
- Genomics
Background:
- The metabolic switch between oxidative phosphorylation (OXPHOS) and aerobic glycolysis is crucial in tumor biology.
- Dynamic regulation of this switch during pancreatic neuroendocrine tumor (pNET) cell differentiation is poorly understood at single-cell resolution.
Purpose of the Study:
- To investigate the metabolic reprogramming of pNET cells during differentiation using single-cell RNA sequencing.
- To identify key molecular regulators and signaling pathways involved in metabolic state transitions in pNETs.
Main Methods:
- Analysis of publicly available single-cell RNA sequencing data from pNETs.
- Pseudotime ordering, dimensionality reduction, and co-expression network construction for metabolic state estimation.
- Validation of gene expression patterns using qRT-PCR and ELISA in pNET cell lines.
Main Results:
- Identified ten transcriptionally distinct cell clusters, including dominant PT-like tumor cells.
- Characterized three metabolic states: OXPHOS-high, Mixed, and Glycolysis-high, varying across PT sub-clusters.
- Discovered MALAT1 as a key discriminative feature and identified prominent intercellular signaling axes (e.g., TGFB1, SPP1, VEGFA).
Conclusions:
- pNET cell metabolism shifts from OXPHOS-dominant to glycolysis-dominant states along the differentiation trajectory.
- MALAT1, ATP5F1B, PKM, and NDUFS1 are identified as key regulatory nodes in this metabolic reprogramming.
- Targeting the OXPHOS-to-glycolysis transition presents a potential therapeutic strategy for pancreatic neuroendocrine tumors.

